The Natural History of Chronic Pancreatitis

Sponsor
Changhai Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03324698
Collaborator
Shenzhen People's Hospital (Other), Zhongda Hospital (Other), Qingdao University (Other), Jiangdu Hospital of Traditional Chinese Medicine (Other), Yangzhou University (Other), 307 Hospital of PLA (Other), The First People's Hospital of Hefei (Other), Nanjing PLA General Hospital (Other), The Second Artillery General Hospital (Other), Wulumuqi General Hospital of Lanzhou Military Command (Other), Central Hospital of Zaozhuang Mining Group (Other), Air Force General Hospital of the PLA (Other)
4,000
1
224
17.9

Study Details

Study Description

Brief Summary

Chronic pancreatitis (CP) is a disease characterized by inflammation and their replacement by fibrotic tissue. The destruction of pancreatic function and structure are the main complications. This retrospective-prospective, multicenter, cohort study was conducted. This study aimed to observe the natural history of CP in China, analyse the risk factors for CP complications, and establish individual predictions.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    In order to track changes consistently throughout the course of CP and facilitate the evaluation and study of CP, a dedicated database, CP Database (version number 2.1, YINMA Information Technology Inc., Shanghai, China), was established to collect clinical data of CP patients who were admitted to our centers. Data befor CP Database established were retrospectively collected according to the electronic medical record system and complemented through telephone, letter, and e-mail inquiries. Data were prospectively collected since CP Database was established. The following information was documented in detail: demographic data (age, sex, birthplace, et al), course of CP, medical history, history of other diseases, smoking and alcohol history, family history of pancreatic diseases and diabetes mellitus (DM), laboratory and imaging findings, and treatment strategy.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    4000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    The Natural History of Chronic Pancreatitis: A Multicenter Study
    Actual Study Start Date :
    Jan 1, 2000
    Anticipated Primary Completion Date :
    Dec 31, 2017
    Anticipated Study Completion Date :
    Aug 31, 2018

    Outcome Measures

    Primary Outcome Measures

    1. Pancreatic cancer [Dec 31, 2017]

      Pancreatic cancer developed in chronic pancreatitis patients

    2. Diabetes mellitus [Dec 31, 2017]

      Endocrine insufficiency developed in chronic pancreatitis patients

    3. Steatorrhea [Dec 31, 2017]

      Exocrine insufficiency developed in chronic pancreatitis patients

    4. Pancreatic pseudocyst [Dec 31, 2017]

      Pancreatic pseudocyst developed in chronic pancreatitis patients

    5. Common bile duct stricture [Dec 31, 2017]

      Common bile duct stricture developed in chronic pancreatitis patients

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients diagnosed with chronic pancreatitis according to Asia-Pacific consensus
    Exclusion Criteria:
    • Pancreatic cancer diagnosed within 2 years after the diagnosis of chronic pancreatitis

    • Groove pancreatitis

    • Autoimmune pancreatitis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Changhai Hospital, Second Military Medical University Shanghai China 200433

    Sponsors and Collaborators

    • Changhai Hospital
    • Shenzhen People's Hospital
    • Zhongda Hospital
    • Qingdao University
    • Jiangdu Hospital of Traditional Chinese Medicine
    • Yangzhou University
    • 307 Hospital of PLA
    • The First People's Hospital of Hefei
    • Nanjing PLA General Hospital
    • The Second Artillery General Hospital
    • Wulumuqi General Hospital of Lanzhou Military Command
    • Central Hospital of Zaozhuang Mining Group
    • Air Force General Hospital of the PLA

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Zhaoshen Li, Director of Gastroenterology Dept., Changhai Hospital
    ClinicalTrials.gov Identifier:
    NCT03324698
    Other Study ID Numbers:
    • Changhai-171024
    First Posted:
    Oct 30, 2017
    Last Update Posted:
    Oct 30, 2017
    Last Verified:
    Oct 1, 2017
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 30, 2017